This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Marc Jacob, PhD
Executive Director of Business Development at SK pharmteco


Dr. Marc Jacob is Executive Director of Business Development at SK pharmteco. SK pharmteco is a global CDMO that provide state-of-the-art analytical, testing and manufacturing services for the pharmaceutical/biotechnology industry across small molecules, peptide, oligonucleotide, ADC and other Advanced Therapies such as cell and gene therapies. Marc has more than 25 years of experience within the pharmaceutical industry, gaining his experience in research, development and production of small molecules, peptide and oligonucleotides Active Pharmaceutical Ingredients. Since 2020 Marc is Heading the Analytical services business development team at SK pharmteco. Marc earned his Doctorate in Synthetic Organic Chemistry at the University of Montpellier, France with an emphasis on asymmetric synthesis of amino acids and subsequently completed a post doctorate at Texas A&M University under the supervision of Sir Derek Barton (Nobel Laureate 1969).

Agenda Sessions

  • Workshop Leader’s Welcome and Opening Remarks